The contribution of preclinical magnetic resonance imaging and spectroscopy to Huntington’s disease
Huntington’s disease is an inherited disorder characterized by psychiatric, cognitive, and motor symptoms due to degeneration of medium spiny neurons in the striatum. A prodromal phase precedes the onset, lasting decades. Current biomarkers include clinical score and striatal atrophy using Magnetic...
Main Authors: | Jean-Baptiste Pérot, Emmanuel Brouillet, Julien Flament |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnagi.2024.1306312/full |
Similar Items
-
Project-Oriented RF Coil Comparison and Optimization for Preclinical, Single-Voxel MR Spectroscopy of the Rat Visual Cortex at 9.4 T
by: Chang-Hoon Choi, et al.
Published: (2023-01-01) -
Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study
by: Stefan Klöppel, et al.
Published: (2015-10-01) -
Longitudinal Evaluation Using Preclinical 7T-Magnetic Resonance Imaging/Spectroscopy on Prenatally Dose-Dependent Alcohol-Exposed Rats
by: Tensei Nakano, et al.
Published: (2023-04-01) -
Magnetic resonance spectroscopy studies in migraine
by: Simona Nikolova, et al.
Published: (2022-08-01) -
Tiagabine is neuroprotective in the N171-82Q and R6/2 mouse models of Huntington's disease
by: Naoki Masuda, et al.
Published: (2008-06-01)